Registration update: We are at capacity.
We are at capacity, but the waiting list is open.
Thank you to everyone who already registered for the preceptorship. The response has been overwhelming, and we are now at full capacity. Although it is no longer possible to register directly, we have started a waiting list. Please sign up on the event’s page, and we will let you know if and when a space becomes available.
Date: 17 – 18 August 2018. The event will commence on Friday at 10am and conclude on Saturday at 4pm.
Venue: Sheraton Melbourne Hotel, 27 Little Collins Street, Melbourne, Victoria
Course Convener: A/Prof Nick Pavlakis supported by Dr Antony Mersiades
Applications: Places are limited to a maximum of 50 people.
Travel and accommodation: Will be provided to successful applicants.
The applications are now open on the event’s page.
How do I apply?
Applications close on the 20 July 2018.
||This intensive and active learning program where participants are divided into small groups with an allocated preceptor, who is a senior ALTG member with clinical expertise in lung cancer management. Participants are expected to make a short presentation of a selected clinical study deemed to be of high importance to clinical practice, to their peers with active discussion. Preceptors provide feedback and guidance before and during the 1.5-2 day session, which also involves discussion and application of clinical trial methodology leading to an interactive demonstration of how to design a trial addressing a clinical question agreed to by the participants.
The objectives of the program are:
- to critically appraise and evaluate key evidence supporting the evolution of clinical practice of lung cancer diagnosis and management, in early and advanced settings, incorporating supportive care, modern treatments and technologies, including modern molecular technology and immune-profiling for selection of targeted therapies and immunotherapy.
- to appreciate the importance of multidisciplinary team care
- to appreciate the importance of clinical inquiry as the basis for clinical research
- to appreciate the basics of clinical trial design